Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 4.87143181 |
2 | desmosome organization (GO:0002934) | 4.82582222 |
3 | NADH metabolic process (GO:0006734) | 4.50268925 |
4 | viral transcription (GO:0019083) | 4.34103614 |
5 | translational termination (GO:0006415) | 4.22753525 |
6 | maturation of SSU-rRNA (GO:0030490) | 4.20632595 |
7 | translational elongation (GO:0006414) | 3.83662766 |
8 | thrombin receptor signaling pathway (GO:0070493) | 3.80535347 |
9 | protein maturation by protein folding (GO:0022417) | 3.79963082 |
10 | ribosomal small subunit biogenesis (GO:0042274) | 3.74109125 |
11 | formation of translation preinitiation complex (GO:0001731) | 3.67076178 |
12 | proline biosynthetic process (GO:0006561) | 3.65473330 |
13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.62587064 |
14 | ribosomal large subunit biogenesis (GO:0042273) | 3.61272229 |
15 | Golgi transport vesicle coating (GO:0048200) | 3.57737853 |
16 | COPI coating of Golgi vesicle (GO:0048205) | 3.57737853 |
17 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57624989 |
18 | protein targeting to ER (GO:0045047) | 3.52424767 |
19 | translational initiation (GO:0006413) | 3.50382632 |
20 | cotranslational protein targeting to membrane (GO:0006613) | 3.48025681 |
21 | viral life cycle (GO:0019058) | 3.38594461 |
22 | regulation of metalloenzyme activity (GO:0048552) | 3.34619673 |
23 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.32899303 |
24 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.32855580 |
25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.32365204 |
26 | extracellular fibril organization (GO:0043206) | 3.32283255 |
27 | pinocytosis (GO:0006907) | 3.31916141 |
28 | protein localization to endoplasmic reticulum (GO:0070972) | 3.31817897 |
29 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.27059204 |
30 | cellular protein complex disassembly (GO:0043624) | 3.26649349 |
31 | DNA deamination (GO:0045006) | 3.23395507 |
32 | cell-substrate junction assembly (GO:0007044) | 3.19317332 |
33 | peptide catabolic process (GO:0043171) | 3.09230008 |
34 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08198616 |
35 | platelet aggregation (GO:0070527) | 3.07854188 |
36 | platelet degranulation (GO:0002576) | 3.07054434 |
37 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.04250111 |
38 | fibril organization (GO:0097435) | 3.03826093 |
39 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.03402571 |
40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.01635341 |
41 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 3.01204551 |
42 | fibrinolysis (GO:0042730) | 3.00997584 |
43 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.98577305 |
44 | cyclooxygenase pathway (GO:0019371) | 2.94470315 |
45 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.93076346 |
46 | nucleobase biosynthetic process (GO:0046112) | 2.92104239 |
47 | regulation of cholesterol esterification (GO:0010872) | 2.91431046 |
48 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.89907623 |
49 | L-phenylalanine metabolic process (GO:0006558) | 2.87091562 |
50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.87091562 |
51 | purine nucleotide salvage (GO:0032261) | 2.83094404 |
52 | proline metabolic process (GO:0006560) | 2.81715835 |
53 | proteasome assembly (GO:0043248) | 2.81703632 |
54 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.81665689 |
55 | surfactant homeostasis (GO:0043129) | 2.81268278 |
56 | purine nucleobase biosynthetic process (GO:0009113) | 2.81198055 |
57 | negative regulation of hemostasis (GO:1900047) | 2.79994501 |
58 | negative regulation of blood coagulation (GO:0030195) | 2.79994501 |
59 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.79882178 |
60 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.79403153 |
61 | intestinal absorption (GO:0050892) | 2.79319425 |
62 | protein complex disassembly (GO:0043241) | 2.78830123 |
63 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.78202344 |
64 | angiogenesis involved in wound healing (GO:0060055) | 2.74648643 |
65 | DNA strand elongation (GO:0022616) | 2.74570322 |
66 | cell-substrate adherens junction assembly (GO:0007045) | 2.73964527 |
67 | focal adhesion assembly (GO:0048041) | 2.73964527 |
68 | hemidesmosome assembly (GO:0031581) | 2.73721639 |
69 | translation (GO:0006412) | 2.72033316 |
70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.71173277 |
71 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.70308358 |
72 | negative regulation of coagulation (GO:0050819) | 2.70015983 |
73 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.68693874 |
74 | mesodermal cell differentiation (GO:0048333) | 2.68291142 |
75 | primary alcohol catabolic process (GO:0034310) | 2.67368323 |
76 | IMP biosynthetic process (GO:0006188) | 2.67353766 |
77 | ribosome biogenesis (GO:0042254) | 2.66197142 |
78 | protein carboxylation (GO:0018214) | 2.65849839 |
79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.65849839 |
80 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65243280 |
81 | ethanol oxidation (GO:0006069) | 2.65042995 |
82 | adherens junction assembly (GO:0034333) | 2.62993561 |
83 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.62869447 |
84 | nitrogen cycle metabolic process (GO:0071941) | 2.62786625 |
85 | L-ascorbic acid metabolic process (GO:0019852) | 2.62637193 |
86 | DNA replication initiation (GO:0006270) | 2.61923301 |
87 | urea cycle (GO:0000050) | 2.61178734 |
88 | macromolecular complex disassembly (GO:0032984) | 2.60781177 |
89 | tricarboxylic acid cycle (GO:0006099) | 2.60193004 |
90 | regulation of water loss via skin (GO:0033561) | 2.59453837 |
91 | IMP metabolic process (GO:0046040) | 2.59330172 |
92 | pentose-phosphate shunt (GO:0006098) | 2.56921219 |
93 | ribosome assembly (GO:0042255) | 2.56626040 |
94 | ethanol metabolic process (GO:0006067) | 2.56234376 |
95 | mitotic nuclear envelope disassembly (GO:0007077) | 2.55457570 |
96 | high-density lipoprotein particle remodeling (GO:0034375) | 2.54485989 |
97 | regulation of cardioblast differentiation (GO:0051890) | 2.54279725 |
98 | galactose catabolic process (GO:0019388) | 2.53494295 |
99 | urea metabolic process (GO:0019627) | 2.52480313 |
100 | hydrogen peroxide catabolic process (GO:0042744) | 2.52289340 |
101 | positive regulation of receptor recycling (GO:0001921) | 2.51424780 |
102 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.50397988 |
103 | gap junction assembly (GO:0016264) | 2.50147909 |
104 | AMP metabolic process (GO:0046033) | 2.49233656 |
105 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.48914232 |
106 | NADPH regeneration (GO:0006740) | 2.48820265 |
107 | telomere maintenance via recombination (GO:0000722) | 2.48571566 |
108 | protein targeting to membrane (GO:0006612) | 2.47812199 |
109 | barbed-end actin filament capping (GO:0051016) | 2.47445561 |
110 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.46955109 |
111 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.46527008 |
112 | L-phenylalanine catabolic process (GO:0006559) | 2.46492473 |
113 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46492473 |
114 | renal system process involved in regulation of blood volume (GO:0001977) | 2.46381237 |
115 | hypotonic response (GO:0006971) | 2.46018570 |
116 | nucleoside salvage (GO:0043174) | 2.44201046 |
117 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.43969796 |
118 | rRNA processing (GO:0006364) | 2.43480249 |
119 | positive regulation of pseudopodium assembly (GO:0031274) | 2.43333543 |
120 | skin morphogenesis (GO:0043589) | 2.43029401 |
121 | low-density lipoprotein particle remodeling (GO:0034374) | 2.42793080 |
122 | multicellular organismal water homeostasis (GO:0050891) | 2.41659288 |
123 | negative regulation of wound healing (GO:0061045) | 2.41656291 |
124 | angiotensin maturation (GO:0002003) | 2.41199604 |
125 | folic acid metabolic process (GO:0046655) | 2.40878138 |
126 | muscle cell migration (GO:0014812) | 2.40522020 |
127 | mRNA catabolic process (GO:0006402) | 2.38393667 |
128 | regulation of cholesterol homeostasis (GO:2000188) | 2.37028481 |
129 | stress fiber assembly (GO:0043149) | 2.36016245 |
130 | morphogenesis of an endothelium (GO:0003159) | 2.34190123 |
131 | endothelial tube morphogenesis (GO:0061154) | 2.34190123 |
132 | negative regulation of stress fiber assembly (GO:0051497) | 2.34157921 |
133 | rRNA metabolic process (GO:0016072) | 2.34139946 |
134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.33948408 |
135 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.33901389 |
136 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33901389 |
137 | lipoxygenase pathway (GO:0019372) | 2.33500389 |
138 | oxidative phosphorylation (GO:0006119) | 2.33139449 |
139 | glucose catabolic process (GO:0006007) | 2.32363626 |
140 | DNA replication checkpoint (GO:0000076) | 2.32351038 |
141 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.32166939 |
142 | cellular glucuronidation (GO:0052695) | 2.31380817 |
143 | membrane disassembly (GO:0030397) | 2.31343253 |
144 | nuclear envelope disassembly (GO:0051081) | 2.31343253 |
145 | T cell apoptotic process (GO:0070231) | 2.30959613 |
146 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.30273642 |
147 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.30174101 |
148 | complement activation, classical pathway (GO:0006958) | 2.29842046 |
149 | GDP-mannose metabolic process (GO:0019673) | 2.29822618 |
150 | establishment of skin barrier (GO:0061436) | 2.29432803 |
151 | DNA unwinding involved in DNA replication (GO:0006268) | 2.29196535 |
152 | endothelium development (GO:0003158) | 2.29122013 |
153 | positive regulation of hemostasis (GO:1900048) | 2.29029641 |
154 | positive regulation of blood coagulation (GO:0030194) | 2.29029641 |
155 | RNA catabolic process (GO:0006401) | 2.28951543 |
156 | mitotic metaphase plate congression (GO:0007080) | 2.28500325 |
157 | purine-containing compound salvage (GO:0043101) | 2.28380192 |
158 | atrioventricular valve morphogenesis (GO:0003181) | 2.28125888 |
159 | glucuronate metabolic process (GO:0019585) | 2.28020218 |
160 | sarcomere organization (GO:0045214) | 2.27777732 |
161 | nucleotide salvage (GO:0043173) | 2.26978297 |
162 | telomere maintenance via telomere lengthening (GO:0010833) | 2.26835300 |
163 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.26393783 |
164 | regulation of spindle organization (GO:0090224) | 2.25784932 |
165 | cellular component biogenesis (GO:0044085) | 2.24927759 |
166 | mitotic recombination (GO:0006312) | 2.24099999 |
167 | hepatocyte apoptotic process (GO:0097284) | 2.23330633 |
168 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.23055560 |
169 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.21796126 |
170 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.20977880 |
171 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.20977880 |
172 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.20229985 |
173 | pseudouridine synthesis (GO:0001522) | 2.19769077 |
174 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.19453984 |
175 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.18979207 |
176 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.18979207 |
177 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.18979207 |
178 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.18913115 |
179 | CENP-A containing nucleosome assembly (GO:0034080) | 2.18531926 |
180 | epithelial cell-cell adhesion (GO:0090136) | 2.17861705 |
181 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.17493096 |
182 | regulation of mitotic spindle organization (GO:0060236) | 2.17245114 |
183 | chromatin remodeling at centromere (GO:0031055) | 2.16672989 |
184 | muscle filament sliding (GO:0030049) | 2.16620401 |
185 | actin-myosin filament sliding (GO:0033275) | 2.16620401 |
186 | regulation of integrin activation (GO:0033623) | 2.16243789 |
187 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.16084502 |
188 | negative regulation of ligase activity (GO:0051352) | 2.16084502 |
189 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.15860553 |
190 | protein localization to kinetochore (GO:0034501) | 2.15398615 |
191 | regulation of tight junction assembly (GO:2000810) | 2.14523526 |
192 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.14380659 |
193 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.14380659 |
194 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.12469931 |
195 | regulation of G0 to G1 transition (GO:0070316) | 2.10811356 |
196 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.10381817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.05864656 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.36516651 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.62185443 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.45437004 |
5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.36047360 |
6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32967562 |
7 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27433115 |
8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25166135 |
9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24282158 |
10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23465446 |
11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.18195475 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.09343986 |
13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.03348938 |
14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.02999120 |
15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.00112602 |
16 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.99224560 |
17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.94903381 |
18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.94260984 |
19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90068877 |
20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87818338 |
21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86778889 |
22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86459534 |
23 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81596677 |
24 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.80103804 |
25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.78713732 |
26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76343240 |
27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75988741 |
28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75879387 |
29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.74230438 |
30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72550027 |
31 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71951752 |
32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71365655 |
33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70306647 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68922325 |
35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66532136 |
36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.64758637 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61071229 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59087256 |
39 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54519581 |
40 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53728893 |
41 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.50734486 |
42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50293586 |
43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.49330563 |
44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49312577 |
45 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48422785 |
46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48301112 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47081270 |
48 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.46535474 |
49 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.46237523 |
50 | MYC_22102868_ChIP-Seq_BL_Human | 1.43978630 |
51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43851932 |
52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42437975 |
53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41543711 |
54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.40847128 |
55 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.36973056 |
56 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36931552 |
57 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35077540 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34863386 |
59 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32080768 |
60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31471362 |
61 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31394831 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30749546 |
63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30210012 |
64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29508242 |
65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28630454 |
66 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.28072227 |
67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27918103 |
68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27145209 |
69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27096028 |
70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.27026177 |
71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26962501 |
72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26770079 |
73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26566305 |
74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25804035 |
75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25729788 |
76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24697869 |
77 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24387464 |
78 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22539167 |
79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21545217 |
80 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19283390 |
81 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19190364 |
82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19156727 |
83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17303422 |
84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.16736735 |
85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15811963 |
86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14659841 |
87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14241143 |
88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14141463 |
89 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13649895 |
90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13212061 |
91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12506298 |
92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11796243 |
93 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11567619 |
94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11220446 |
95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.10864579 |
96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09305610 |
97 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08784215 |
98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08537014 |
99 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08478336 |
100 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.08171069 |
101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07790854 |
102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07770628 |
103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06478635 |
104 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06012701 |
105 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05163918 |
106 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04582038 |
107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03670235 |
108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02830265 |
109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02449236 |
110 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01993806 |
111 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01167080 |
112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01126340 |
113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00952906 |
114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00325739 |
115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00183050 |
116 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00166435 |
117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99543664 |
118 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99285748 |
119 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99154331 |
120 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99127521 |
121 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99127521 |
122 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98843967 |
123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98283094 |
124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98050886 |
125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.97789338 |
126 | MAF_26560356_Chip-Seq_TH1_Human | 0.97302764 |
127 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97149370 |
128 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97121806 |
129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97042308 |
130 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97009837 |
131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96560571 |
132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96458863 |
133 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95556147 |
134 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95381210 |
135 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.95043884 |
136 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95034369 |
137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94936357 |
138 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94802724 |
139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94697108 |
140 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94429177 |
141 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94210444 |
142 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93791126 |
143 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93563810 |
144 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92092677 |
145 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92017365 |
146 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91846792 |
147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.91087063 |
148 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90375545 |
149 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90058994 |
150 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.89961065 |
151 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.89306642 |
152 | P68_20966046_ChIP-Seq_HELA_Human | 0.88038220 |
153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87662084 |
154 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.87360587 |
155 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.87150554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 3.34189842 |
2 | MP0006054_spinal_hemorrhage | 2.88909269 |
3 | MP0005360_urolithiasis | 2.87951884 |
4 | MP0003693_abnormal_embryo_hatching | 2.60363408 |
5 | MP0010352_gastrointestinal_tract_polyps | 2.56759462 |
6 | MP0003705_abnormal_hypodermis_morpholog | 2.51147969 |
7 | MP0002139_abnormal_hepatobiliary_system | 2.47860034 |
8 | MP0003806_abnormal_nucleotide_metabolis | 2.47473416 |
9 | MP0010234_abnormal_vibrissa_follicle | 2.37534061 |
10 | MP0003566_abnormal_cell_adhesion | 2.20794731 |
11 | MP0004957_abnormal_blastocyst_morpholog | 2.18148939 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.14206062 |
13 | MP0000678_abnormal_parathyroid_gland | 2.01873857 |
14 | MP0009840_abnormal_foam_cell | 1.98509981 |
15 | MP0002396_abnormal_hematopoietic_system | 1.96847457 |
16 | MP0008004_abnormal_stomach_pH | 1.85035054 |
17 | MP0005023_abnormal_wound_healing | 1.84694507 |
18 | MP0010368_abnormal_lymphatic_system | 1.84448360 |
19 | MP0003279_aneurysm | 1.81790404 |
20 | MP0005085_abnormal_gallbladder_physiolo | 1.77884465 |
21 | MP0003724_increased_susceptibility_to | 1.77262200 |
22 | MP0000490_abnormal_crypts_of | 1.76945734 |
23 | MP0005451_abnormal_body_composition | 1.73680050 |
24 | MP0005365_abnormal_bile_salt | 1.66297491 |
25 | MP0005275_abnormal_skin_tensile | 1.59778454 |
26 | MP0003077_abnormal_cell_cycle | 1.59238695 |
27 | MP0008007_abnormal_cellular_replicative | 1.54187096 |
28 | MP0005670_abnormal_white_adipose | 1.51538725 |
29 | MP0003111_abnormal_nucleus_morphology | 1.50329605 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.50312213 |
31 | MP0004084_abnormal_cardiac_muscle | 1.46019244 |
32 | MP0000751_myopathy | 1.44979316 |
33 | MP0006138_congestive_heart_failure | 1.42694696 |
34 | MP0005397_hematopoietic_system_phenotyp | 1.40971486 |
35 | MP0001545_abnormal_hematopoietic_system | 1.40971486 |
36 | MP0001873_stomach_inflammation | 1.38420369 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.37450331 |
38 | MP0004272_abnormal_basement_membrane | 1.37086075 |
39 | MP0010094_abnormal_chromosome_stability | 1.36960351 |
40 | MP0010155_abnormal_intestine_physiology | 1.36223912 |
41 | MP0003941_abnormal_skin_development | 1.35408070 |
42 | MP0000858_altered_metastatic_potential | 1.33569315 |
43 | MP0000750_abnormal_muscle_regeneration | 1.33110893 |
44 | MP0009379_abnormal_foot_pigmentation | 1.33053115 |
45 | MP0005165_increased_susceptibility_to | 1.32074019 |
46 | MP0004019_abnormal_vitamin_homeostasis | 1.31041907 |
47 | MP0000467_abnormal_esophagus_morphology | 1.27216472 |
48 | MP0003763_abnormal_thymus_physiology | 1.26180815 |
49 | MP0002060_abnormal_skin_morphology | 1.25869028 |
50 | MP0003186_abnormal_redox_activity | 1.25255888 |
51 | MP0010030_abnormal_orbit_morphology | 1.23270111 |
52 | MP0002138_abnormal_hepatobiliary_system | 1.22692910 |
53 | MP0003828_pulmonary_edema | 1.21810947 |
54 | MP0002132_abnormal_respiratory_system | 1.17553066 |
55 | MP0009384_cardiac_valve_regurgitation | 1.15806600 |
56 | MP0000749_muscle_degeneration | 1.15662777 |
57 | MP0004036_abnormal_muscle_relaxation | 1.14982939 |
58 | MP0002877_abnormal_melanocyte_morpholog | 1.14246127 |
59 | MP0009643_abnormal_urine_homeostasis | 1.14100958 |
60 | MP0004808_abnormal_hematopoietic_stem | 1.13965615 |
61 | MP0005058_abnormal_lysosome_morphology | 1.13312198 |
62 | MP0000685_abnormal_immune_system | 1.12995722 |
63 | MP0008260_abnormal_autophagy | 1.12693331 |
64 | MP0001879_abnormal_lymphatic_vessel | 1.10243292 |
65 | MP0000350_abnormal_cell_proliferation | 1.08797102 |
66 | MP0003567_abnormal_fetal_cardiomyocyte | 1.07860484 |
67 | MP0001958_emphysema | 1.06448488 |
68 | MP0001730_embryonic_growth_arrest | 1.06410854 |
69 | MP0001661_extended_life_span | 1.06278905 |
70 | MP0003984_embryonic_growth_retardation | 1.05253659 |
71 | MP0005330_cardiomyopathy | 1.04857526 |
72 | MP0005623_abnormal_meninges_morphology | 1.03829113 |
73 | MP0005257_abnormal_intraocular_pressure | 1.03676175 |
74 | MP0009053_abnormal_anal_canal | 1.02566083 |
75 | MP0002088_abnormal_embryonic_growth/wei | 1.02551347 |
76 | MP0001243_abnormal_dermal_layer | 1.02275242 |
77 | MP0010329_abnormal_lipoprotein_level | 1.01892242 |
78 | MP0002254_reproductive_system_inflammat | 1.01633943 |
79 | MP0005409_darkened_coat_color | 1.01137750 |
80 | MP0001853_heart_inflammation | 1.00134223 |
81 | MP0008932_abnormal_embryonic_tissue | 0.99882648 |
82 | MP0002972_abnormal_cardiac_muscle | 0.98653795 |
83 | MP0001542_abnormal_bone_strength | 0.98328981 |
84 | MP0005332_abnormal_amino_acid | 0.98056698 |
85 | MP0002086_abnormal_extraembryonic_tissu | 0.97488785 |
86 | MP0000477_abnormal_intestine_morphology | 0.97473568 |
87 | MP0004264_abnormal_extraembryonic_tissu | 0.97384580 |
88 | MP0003950_abnormal_plasma_membrane | 0.97189085 |
89 | MP0005666_abnormal_adipose_tissue | 0.97107481 |
90 | MP0005083_abnormal_biliary_tract | 0.96762454 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.96648964 |
92 | MP0000762_abnormal_tongue_morphology | 0.96212863 |
93 | MP0009780_abnormal_chondrocyte_physiolo | 0.96038142 |
94 | MP0004947_skin_inflammation | 0.95068881 |
95 | MP0005380_embryogenesis_phenotype | 0.94214065 |
96 | MP0001672_abnormal_embryogenesis/_devel | 0.94214065 |
97 | MP0002019_abnormal_tumor_incidence | 0.93828869 |
98 | MP0003718_maternal_effect | 0.93508924 |
99 | MP0000767_abnormal_smooth_muscle | 0.93167191 |
100 | MP0003786_premature_aging | 0.93093446 |
101 | MP0008775_abnormal_heart_ventricle | 0.91634767 |
102 | MP0000343_altered_response_to | 0.90717285 |
103 | MP0003183_abnormal_peptide_metabolism | 0.90241849 |
104 | MP0009785_altered_susceptibility_to | 0.90053238 |
105 | MP0000249_abnormal_blood_vessel | 0.89708107 |
106 | MP0000465_gastrointestinal_hemorrhage | 0.87574887 |
107 | MP0010630_abnormal_cardiac_muscle | 0.86706731 |
108 | MP0002166_altered_tumor_susceptibility | 0.86245227 |
109 | MP0000733_abnormal_muscle_development | 0.86115254 |
110 | MP0000579_abnormal_nail_morphology | 0.85583353 |
111 | MP0005501_abnormal_skin_physiology | 0.84527773 |
112 | MP0002405_respiratory_system_inflammati | 0.83976883 |
113 | MP0006036_abnormal_mitochondrial_physio | 0.83330504 |
114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83221933 |
115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82466055 |
116 | MP0003868_abnormal_feces_composition | 0.82278664 |
117 | MP0001915_intracranial_hemorrhage | 0.81745006 |
118 | MP0001697_abnormal_embryo_size | 0.81449386 |
119 | MP0005503_abnormal_tendon_morphology | 0.80327908 |
120 | MP0002722_abnormal_immune_system | 0.79511057 |
121 | MP0003300_gastrointestinal_ulcer | 0.79431006 |
122 | MP0004782_abnormal_surfactant_physiolog | 0.78688826 |
123 | MP0001666_abnormal_nutrient_absorption | 0.78551509 |
124 | MP0002080_prenatal_lethality | 0.78508364 |
125 | MP0004087_abnormal_muscle_fiber | 0.77156294 |
126 | MP0002398_abnormal_bone_marrow | 0.76421958 |
127 | MP0005385_cardiovascular_system_phenoty | 0.75176967 |
128 | MP0001544_abnormal_cardiovascular_syste | 0.75176967 |
129 | MP0005375_adipose_tissue_phenotype | 0.75093461 |
130 | MP0010771_integument_phenotype | 0.74579303 |
131 | MP0001216_abnormal_epidermal_layer | 0.73828999 |
132 | MP0003091_abnormal_cell_migration | 0.73210487 |
133 | MP0005166_decreased_susceptibility_to | 0.72575595 |
134 | MP0001849_ear_inflammation | 0.72425463 |
135 | MP0003448_altered_tumor_morphology | 0.72251209 |
136 | MP0000003_abnormal_adipose_tissue | 0.71980695 |
137 | MP0002128_abnormal_blood_circulation | 0.70910319 |
138 | MP0000566_synostosis | 0.70556874 |
139 | MP0000689_abnormal_spleen_morphology | 0.69612436 |
140 | MP0002796_impaired_skin_barrier | 0.68938376 |
141 | MP0002429_abnormal_blood_cell | 0.68186706 |
142 | MP0003866_abnormal_defecation | 0.67553281 |
143 | MP0002136_abnormal_kidney_physiology | 0.67039729 |
144 | MP0009931_abnormal_skin_appearance | 0.66582741 |
145 | MP0000313_abnormal_cell_death | 0.66372720 |
146 | MP0003252_abnormal_bile_duct | 0.66010850 |
147 | MP0002269_muscular_atrophy | 0.65991134 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Menorrhagia (HP:0000132) | 5.01567421 |
2 | Prolonged bleeding time (HP:0003010) | 4.11241315 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 4.10091518 |
4 | Protrusio acetabuli (HP:0003179) | 4.00976785 |
5 | Purpura (HP:0000979) | 3.99174336 |
6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.35028813 |
7 | Premature rupture of membranes (HP:0001788) | 3.33040446 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.25594994 |
9 | Abnormal number of erythroid precursors (HP:0012131) | 3.23950361 |
10 | Abnormal hemoglobin (HP:0011902) | 3.06926452 |
11 | Epistaxis (HP:0000421) | 3.05433086 |
12 | Increased connective tissue (HP:0009025) | 3.03493715 |
13 | Trismus (HP:0000211) | 3.01527379 |
14 | Reticulocytopenia (HP:0001896) | 2.89749846 |
15 | Abnormal platelet function (HP:0011869) | 2.88958200 |
16 | Impaired platelet aggregation (HP:0003540) | 2.88958200 |
17 | Ventricular tachycardia (HP:0004756) | 2.88715200 |
18 | Malnutrition (HP:0004395) | 2.82965009 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72537411 |
20 | Gingival bleeding (HP:0000225) | 2.70998948 |
21 | Aplastic anemia (HP:0001915) | 2.65711839 |
22 | Distal lower limb muscle weakness (HP:0009053) | 2.61283358 |
23 | Atrophic scars (HP:0001075) | 2.58755015 |
24 | Aortic aneurysm (HP:0004942) | 2.57856238 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 2.56611491 |
26 | Thrombocytosis (HP:0001894) | 2.56344289 |
27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.55566678 |
28 | Pustule (HP:0200039) | 2.53014551 |
29 | Vascular calcification (HP:0004934) | 2.52940798 |
30 | Oral leukoplakia (HP:0002745) | 2.48956220 |
31 | Deep venous thrombosis (HP:0002625) | 2.47757134 |
32 | Distal lower limb amyotrophy (HP:0008944) | 2.47488686 |
33 | Nemaline bodies (HP:0003798) | 2.46791914 |
34 | Ileus (HP:0002595) | 2.45675400 |
35 | Multiple enchondromatosis (HP:0005701) | 2.45040576 |
36 | Hyperlipoproteinemia (HP:0010980) | 2.44187244 |
37 | Hemorrhage of the eye (HP:0011885) | 2.41577182 |
38 | Xanthomatosis (HP:0000991) | 2.40526044 |
39 | Selective tooth agenesis (HP:0001592) | 2.39339830 |
40 | Cardiovascular calcification (HP:0011915) | 2.37548563 |
41 | Vertebral compression fractures (HP:0002953) | 2.34038850 |
42 | Gastrointestinal stroma tumor (HP:0100723) | 2.32781693 |
43 | Abnormality of the Achilles tendon (HP:0005109) | 2.32050437 |
44 | Fragile skin (HP:0001030) | 2.31896680 |
45 | Microretrognathia (HP:0000308) | 2.31185914 |
46 | Breast hypoplasia (HP:0003187) | 2.29087680 |
47 | Intrahepatic cholestasis (HP:0001406) | 2.28411449 |
48 | Type 1 muscle fiber predominance (HP:0003803) | 2.27600329 |
49 | Nonimmune hydrops fetalis (HP:0001790) | 2.22915087 |
50 | Lipoatrophy (HP:0100578) | 2.22537866 |
51 | Aortic dissection (HP:0002647) | 2.21007582 |
52 | Systemic lupus erythematosus (HP:0002725) | 2.19642659 |
53 | Sparse eyelashes (HP:0000653) | 2.19424160 |
54 | Joint hemorrhage (HP:0005261) | 2.19278132 |
55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.19244707 |
56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19215376 |
57 | Macrocytic anemia (HP:0001972) | 2.17754582 |
58 | Cervical subluxation (HP:0003308) | 2.11674815 |
59 | Pallor (HP:0000980) | 2.11017335 |
60 | Congenital, generalized hypertrichosis (HP:0004540) | 2.10522255 |
61 | Flat acetabular roof (HP:0003180) | 2.10449631 |
62 | Abnormality of complement system (HP:0005339) | 2.09944400 |
63 | Abnormality of proline metabolism (HP:0010907) | 2.09176199 |
64 | Hydroxyprolinuria (HP:0003080) | 2.09176199 |
65 | Ankle contracture (HP:0006466) | 2.09128469 |
66 | Ridged nail (HP:0001807) | 2.08878083 |
67 | Abnormality of the calcaneus (HP:0008364) | 2.05318899 |
68 | Rhabdomyolysis (HP:0003201) | 2.05216450 |
69 | Distal arthrogryposis (HP:0005684) | 2.05076789 |
70 | Acanthocytosis (HP:0001927) | 2.03793116 |
71 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03763074 |
72 | Rough bone trabeculation (HP:0100670) | 2.03253727 |
73 | Nausea (HP:0002018) | 2.02322332 |
74 | Cerebral aneurysm (HP:0004944) | 2.02242640 |
75 | Difficulty climbing stairs (HP:0003551) | 2.01313206 |
76 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.01027986 |
77 | Colon cancer (HP:0003003) | 2.00407176 |
78 | Abnormality of the umbilical cord (HP:0010881) | 1.99624322 |
79 | Palpitations (HP:0001962) | 1.99428124 |
80 | Gastrointestinal dysmotility (HP:0002579) | 1.99333185 |
81 | Calcaneovalgus deformity (HP:0001848) | 1.98102894 |
82 | Petechiae (HP:0000967) | 1.96830256 |
83 | Emphysema (HP:0002097) | 1.95268584 |
84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.95198421 |
85 | Abnormality of the nasal mucosa (HP:0000433) | 1.95156362 |
86 | Breech presentation (HP:0001623) | 1.94706841 |
87 | Fat malabsorption (HP:0002630) | 1.94003961 |
88 | Short nail (HP:0001799) | 1.93034555 |
89 | Hypobetalipoproteinemia (HP:0003563) | 1.92918617 |
90 | Onycholysis (HP:0001806) | 1.92799126 |
91 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91540144 |
92 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91287333 |
93 | Exercise-induced myalgia (HP:0003738) | 1.90637309 |
94 | Osteolytic defects of the hand bones (HP:0009699) | 1.90507924 |
95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90507924 |
96 | Hyperphosphatemia (HP:0002905) | 1.88569814 |
97 | Plantar hyperkeratosis (HP:0007556) | 1.88024418 |
98 | Spinal rigidity (HP:0003306) | 1.87986490 |
99 | Biconcave vertebral bodies (HP:0004586) | 1.87717522 |
100 | Achilles tendon contracture (HP:0001771) | 1.86039094 |
101 | Increased mean platelet volume (HP:0011877) | 1.85987174 |
102 | Myocardial infarction (HP:0001658) | 1.85334603 |
103 | Peritonitis (HP:0002586) | 1.85017704 |
104 | Back pain (HP:0003418) | 1.84944584 |
105 | Abnormal cartilage morphology (HP:0002763) | 1.82600029 |
106 | Rectal prolapse (HP:0002035) | 1.82313332 |
107 | Birth length less than 3rd percentile (HP:0003561) | 1.81789055 |
108 | Abnormal gallbladder physiology (HP:0012438) | 1.81303141 |
109 | Cholecystitis (HP:0001082) | 1.81303141 |
110 | Muscle fiber splitting (HP:0003555) | 1.81012235 |
111 | Dilated cardiomyopathy (HP:0001644) | 1.80214150 |
112 | Acanthosis nigricans (HP:0000956) | 1.78737624 |
113 | Deformed tarsal bones (HP:0008119) | 1.78679553 |
114 | Abnormal hair laboratory examination (HP:0003328) | 1.78396692 |
115 | Milia (HP:0001056) | 1.77582892 |
116 | Alopecia of scalp (HP:0002293) | 1.77524643 |
117 | Dilatation of the ascending aorta (HP:0005111) | 1.77076354 |
118 | Vascular tortuosity (HP:0004948) | 1.77030793 |
119 | Gout (HP:0001997) | 1.77027534 |
120 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.75784626 |
121 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.75784626 |
122 | Areflexia of lower limbs (HP:0002522) | 1.75742767 |
123 | Glomerulosclerosis (HP:0000096) | 1.75691377 |
124 | Hepatic necrosis (HP:0002605) | 1.74439369 |
125 | Myoglobinuria (HP:0002913) | 1.74028848 |
126 | Abnormal platelet volume (HP:0011876) | 1.73894312 |
127 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73551657 |
128 | Myopathic facies (HP:0002058) | 1.73457774 |
129 | Complement deficiency (HP:0004431) | 1.71989188 |
130 | 11 pairs of ribs (HP:0000878) | 1.71945026 |
131 | Polycythemia (HP:0001901) | 1.71872831 |
132 | Fragile nails (HP:0001808) | 1.70910009 |
133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.70251961 |
134 | Hyporeflexia of lower limbs (HP:0002600) | 1.70002835 |
135 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.69968011 |
136 | Hypolipoproteinemia (HP:0010981) | 1.69585655 |
137 | Abnormal pupillary function (HP:0007686) | 1.69210339 |
138 | Natal tooth (HP:0000695) | 1.69203316 |
139 | Nasal polyposis (HP:0100582) | 1.69125877 |
140 | Abnormality of carpal bone ossification (HP:0006257) | 1.67747798 |
141 | Degeneration of anterior horn cells (HP:0002398) | 1.67379416 |
142 | Abnormality of the anterior horn cell (HP:0006802) | 1.67379416 |
143 | Nail dystrophy (HP:0008404) | 1.67335923 |
144 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66972899 |
145 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66831304 |
146 | Mesangial abnormality (HP:0001966) | 1.66702888 |
147 | Woolly hair (HP:0002224) | 1.66044825 |
148 | Increased density of long bones (HP:0006392) | 1.65936302 |
149 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.65689420 |
150 | Cerebral palsy (HP:0100021) | 1.63446319 |
151 | Ulnar deviation of the wrist (HP:0003049) | 1.63398324 |
152 | Polygenic inheritance (HP:0010982) | 1.62952984 |
153 | Arterial tortuosity (HP:0005116) | 1.62909038 |
154 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.62848328 |
155 | Proximal tubulopathy (HP:0000114) | 1.62819918 |
156 | Neck muscle weakness (HP:0000467) | 1.62772795 |
157 | Beaking of vertebral bodies (HP:0004568) | 1.62599469 |
158 | Abnormal delivery (HP:0001787) | 1.62175973 |
159 | Abnormality of the acetabulum (HP:0003170) | 1.60747251 |
160 | Soft skin (HP:0000977) | 1.60364504 |
161 | Neonatal death (HP:0003811) | 1.59372682 |
162 | Esophageal varix (HP:0002040) | 1.58637874 |
163 | Facial diplegia (HP:0001349) | 1.58467110 |
164 | Pili torti (HP:0003777) | 1.58182409 |
165 | Reduced antithrombin III activity (HP:0001976) | 1.56907911 |
166 | Pterygium (HP:0001059) | 1.56283547 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SMG1 | 3.30849946 |
2 | NME2 | 3.05809025 |
3 | BUB1 | 2.43735673 |
4 | PIM2 | 2.33754183 |
5 | EIF2AK1 | 2.33475717 |
6 | EPHA2 | 2.32926706 |
7 | KDR | 2.29845291 |
8 | TESK1 | 2.21858984 |
9 | RIPK4 | 2.18270502 |
10 | RPS6KB2 | 2.17413082 |
11 | MYLK | 2.03854205 |
12 | TTN | 2.01924944 |
13 | MAPKAPK3 | 2.01820600 |
14 | RPS6KA4 | 1.98430893 |
15 | TGFBR1 | 1.95612858 |
16 | STK10 | 1.94295547 |
17 | TESK2 | 1.83199516 |
18 | WEE1 | 1.77714785 |
19 | VRK2 | 1.76878812 |
20 | ARAF | 1.70897537 |
21 | PKN2 | 1.67975172 |
22 | BMX | 1.62674694 |
23 | ERN1 | 1.56620319 |
24 | LRRK2 | 1.55975625 |
25 | NEK1 | 1.50369908 |
26 | EEF2K | 1.42595704 |
27 | TRIB3 | 1.42499208 |
28 | MST4 | 1.41305808 |
29 | MAP2K3 | 1.39443422 |
30 | MAP3K3 | 1.39002544 |
31 | PAK4 | 1.36095227 |
32 | PIK3CG | 1.31802448 |
33 | MAP3K11 | 1.29624981 |
34 | LIMK1 | 1.28848750 |
35 | MAP4K1 | 1.27465247 |
36 | TRPM7 | 1.25841832 |
37 | ZAK | 1.25498655 |
38 | OBSCN | 1.24523233 |
39 | SIK1 | 1.23541269 |
40 | TIE1 | 1.23210969 |
41 | MAP3K8 | 1.22969143 |
42 | RIPK1 | 1.18972897 |
43 | PDGFRA | 1.17869113 |
44 | AURKB | 1.14548789 |
45 | ZAP70 | 1.13675211 |
46 | PRPF4B | 1.08675127 |
47 | TSSK6 | 1.08086210 |
48 | TTK | 1.06799457 |
49 | PIK3CA | 1.06747379 |
50 | TGFBR2 | 1.06721052 |
51 | ILK | 1.06649487 |
52 | CDC7 | 1.06143621 |
53 | NEK2 | 1.04796110 |
54 | STK38L | 1.03937200 |
55 | JAK3 | 1.03108788 |
56 | EPHB1 | 1.02470232 |
57 | MST1R | 1.01017057 |
58 | CDK7 | 0.99102259 |
59 | MAP3K12 | 0.97187502 |
60 | FLT3 | 0.96320483 |
61 | IRAK3 | 0.94971156 |
62 | CDC42BPA | 0.94812437 |
63 | PRKG2 | 0.94739213 |
64 | TBK1 | 0.92021475 |
65 | EIF2AK3 | 0.92017803 |
66 | SIK3 | 0.91499784 |
67 | ACVR1B | 0.86639223 |
68 | PTK2B | 0.85283496 |
69 | BRSK2 | 0.85069018 |
70 | NME1 | 0.84389409 |
71 | BCKDK | 0.84054887 |
72 | PAK2 | 0.83579013 |
73 | LATS2 | 0.79058567 |
74 | PBK | 0.77663444 |
75 | PLK1 | 0.77112884 |
76 | PLK4 | 0.76561351 |
77 | EPHB2 | 0.76257243 |
78 | DYRK3 | 0.75017910 |
79 | NLK | 0.73639367 |
80 | MAP2K2 | 0.73328082 |
81 | MAP3K10 | 0.73209057 |
82 | NEK9 | 0.72451461 |
83 | CDK8 | 0.71983328 |
84 | PIM1 | 0.70759759 |
85 | PTK6 | 0.70239955 |
86 | DAPK1 | 0.69866985 |
87 | STK24 | 0.68678225 |
88 | VRK1 | 0.68491865 |
89 | CDK9 | 0.67336505 |
90 | MELK | 0.67174257 |
91 | PAK1 | 0.67132843 |
92 | PDPK1 | 0.65221360 |
93 | CSF1R | 0.64734136 |
94 | ICK | 0.64532331 |
95 | MAP2K6 | 0.63721906 |
96 | TLK1 | 0.62958079 |
97 | TYK2 | 0.61419961 |
98 | LMTK2 | 0.61243443 |
99 | BMPR2 | 0.60936055 |
100 | CDK4 | 0.58349707 |
101 | TEC | 0.57286755 |
102 | MET | 0.57071440 |
103 | LATS1 | 0.56554356 |
104 | PTK2 | 0.56444504 |
105 | TAOK1 | 0.56125490 |
106 | TAOK2 | 0.55843368 |
107 | MAPK11 | 0.55370852 |
108 | SCYL2 | 0.54069550 |
109 | PDK2 | 0.53372214 |
110 | DAPK3 | 0.53274392 |
111 | PRKCI | 0.52837609 |
112 | BTK | 0.52743309 |
113 | GRK5 | 0.51833608 |
114 | CDK12 | 0.51603245 |
115 | MAP3K1 | 0.51229457 |
116 | MAPKAPK2 | 0.51081071 |
117 | STK3 | 0.50646582 |
118 | MOS | 0.49259888 |
119 | CDK6 | 0.48505200 |
120 | BRAF | 0.48320491 |
121 | FGFR4 | 0.47126695 |
122 | IKBKB | 0.46471269 |
123 | DMPK | 0.46059655 |
124 | AKT2 | 0.45845840 |
125 | MAP2K1 | 0.44823480 |
126 | AURKA | 0.44702925 |
127 | FER | 0.43923488 |
128 | TAOK3 | 0.42531738 |
129 | MAP3K13 | 0.41575464 |
130 | STK4 | 0.41510612 |
131 | ABL2 | 0.39695982 |
132 | IKBKE | 0.39442366 |
133 | PRKD1 | 0.38939064 |
134 | ROCK2 | 0.36585213 |
135 | MATK | 0.35061915 |
136 | ROCK1 | 0.32089374 |
137 | ERBB4 | 0.30226345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.82192513 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.23769304 |
3 | Proteasome_Homo sapiens_hsa03050 | 2.84943066 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 2.47558514 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.17154232 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12961905 |
7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.07030777 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03443098 |
9 | RNA polymerase_Homo sapiens_hsa03020 | 1.92363177 |
10 | Base excision repair_Homo sapiens_hsa03410 | 1.89289796 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.86131309 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.83363379 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.82725668 |
14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81451733 |
15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.78615007 |
16 | RNA transport_Homo sapiens_hsa03013 | 1.77505976 |
17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.75777981 |
18 | Spliceosome_Homo sapiens_hsa03040 | 1.70524607 |
19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.70470295 |
20 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.66530666 |
21 | Homologous recombination_Homo sapiens_hsa03440 | 1.65190295 |
22 | Cell cycle_Homo sapiens_hsa04110 | 1.63386177 |
23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.59574135 |
24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.58165725 |
25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54782259 |
26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54564552 |
27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.52681170 |
28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48351571 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.48261929 |
30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44334677 |
31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.35834610 |
32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34299244 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32086419 |
34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29704343 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25719041 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25463296 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.21218867 |
38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19275370 |
39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18733580 |
40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13792841 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.11781866 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09480206 |
43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09425712 |
44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06476904 |
45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06383822 |
46 | RNA degradation_Homo sapiens_hsa03018 | 1.05316080 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04070199 |
48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02832057 |
49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02167515 |
50 | Legionellosis_Homo sapiens_hsa05134 | 1.01859114 |
51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01619850 |
52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00495700 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00183526 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99334883 |
55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98278568 |
56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96993848 |
57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96144302 |
58 | Adherens junction_Homo sapiens_hsa04520 | 0.95350182 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92839576 |
60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89287386 |
61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88818080 |
62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87592174 |
63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86761598 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85025727 |
65 | Purine metabolism_Homo sapiens_hsa00230 | 0.84535028 |
66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84344613 |
67 | Bladder cancer_Homo sapiens_hsa05219 | 0.84201887 |
68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83648657 |
69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81500704 |
70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81111820 |
71 | Apoptosis_Homo sapiens_hsa04210 | 0.80597274 |
72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80482810 |
73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80331801 |
74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76315641 |
75 | Malaria_Homo sapiens_hsa05144 | 0.75594673 |
76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74696109 |
77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73558975 |
78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72612764 |
79 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71666248 |
80 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70034916 |
81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68802696 |
82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67766055 |
83 | Measles_Homo sapiens_hsa05162 | 0.67654698 |
84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67374710 |
85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67191615 |
86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66957741 |
87 | Focal adhesion_Homo sapiens_hsa04510 | 0.66850246 |
88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66248107 |
89 | Bile secretion_Homo sapiens_hsa04976 | 0.66163953 |
90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65977501 |
91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65787441 |
92 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65760765 |
93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65481573 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65442387 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65073902 |
96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64739572 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64175613 |
98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.63885152 |
99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63152428 |
100 | Protein export_Homo sapiens_hsa03060 | 0.62587348 |
101 | Asthma_Homo sapiens_hsa05310 | 0.61683638 |
102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61508730 |
103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61231402 |
104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60994571 |
105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60435498 |
106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60178358 |
107 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59547545 |
108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59457307 |
109 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59103997 |
110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58588187 |
111 | Amoebiasis_Homo sapiens_hsa05146 | 0.57960251 |
112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57754375 |
113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57121577 |
114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57046948 |
115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56215072 |
116 | Influenza A_Homo sapiens_hsa05164 | 0.55909197 |
117 | Tight junction_Homo sapiens_hsa04530 | 0.54803793 |
118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54552178 |
119 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53985214 |
120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51888886 |
121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51228420 |
122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51188905 |
123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49696032 |
124 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49091578 |
125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48430687 |
126 | Hepatitis B_Homo sapiens_hsa05161 | 0.47895931 |
127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47857306 |
128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47256141 |
129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47169035 |
130 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45784507 |
131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45664849 |
132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45136914 |
133 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44743506 |
134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43573658 |
135 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43307207 |
136 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42338344 |
137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42195887 |
138 | Pertussis_Homo sapiens_hsa05133 | 0.42154089 |
139 | Allograft rejection_Homo sapiens_hsa05330 | 0.39909127 |
140 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38281100 |
141 | Mineral absorption_Homo sapiens_hsa04978 | 0.35096443 |
142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31487773 |
143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30032507 |
144 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29286784 |
145 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28565693 |
146 | Insulin resistance_Homo sapiens_hsa04931 | 0.28402091 |